The global diagnostic enzymes market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are expected to boost the market growth include the rise in geriatric population that results in the rising prevalence of chronic diseases, growth in popularity of these enzymes in the detection of chronic diseases such as cardiovascular diseases, cancer, pain & inflammatory disorders, adoption of advanced enzymes such as immobilized enzymes owing to higher stability. There is an increased usage of enzymes in diagnostic and biotech applications. However, safety concerns due to the high susceptibility of enzymes toward contamination restrain the market growth. Technological advancements to produce enzymes that have advanced diagnostic features and high resistance against deterioration is a factor that provides a broad range of opportunities for the manufacturers in this market. 

Diagnostic enzymes are types of enzymes or proteins that have special properties such as high specificity and therefore act as a biocatalyst to accelerate the chemical reactions & produce the desired results in a biochemical reaction. Owing to low requirements and a high degree of specificity, these enzymes have witnessed a growth in demand across medical fields. Specialty enzymes have grown in popularity in recent years as a result of their potential uses in a variety of sectors, including pharmaceutical, biotechnology research, and diagnostics. Specialty enzymes are proteins that function as biocatalysts in pharmaceutical and diagnostic processes to speed up reactions and achieve the desired outcomes. Specialty enzymes serve a critical role in the formulation and delivery of drugs in the pharmaceutical industry. Pharmaceutical medication formulations based on enzymes are used to treat chronic diseases including cancer and AIDS. It has long been utilized in biotechnology research, especially in molecular biology. They’re also employed in genetic engineering to cut, duplicate, and attach DNA to meet certain requirements. 

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segment Covered- 

o By Enzyme Type 

o By Application 

• Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape: Sanofi S.A., Thermo Fisher Scientific Inc., and F. Hoffman La-Roche AG, among others. 

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How are players addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Diagnostic Enzymes Market Report by Segment

By Enzyme Type

    • Polymerases and Nucleases

    • Carbohydrases

    • Proteases

    • Oxidases

    • Others

By Application

    • Clinical Chemistry

    • Molecular Diagnostics

    • Others

Global Diagnostic Enzymes Market Report by Region

North America       

    • US

    • Canada

Europe

    • Germany

    • UK

    • France

    • Spain

    • Italy

    • Rest of Europe

Asia-Pacific    

    • China

    • Japan

    • India

    • Rest of Asia-Pacific

Rest of the World

    • Latin America

    • Middle East and Africa